Educational content on VJHemOnc is intended for healthcare professionals only. By visiting this website and accessing this information you confirm that you are a healthcare professional.

Share this video  

iwNHL 2017 | Making cancer treatments more affordable

Steven Rosen • 8 Sep 2017
iwNHL 2017
Non-Hodgkin Lymphoma

Steven Rosen, MD, from the City of Hope, Duarte, CA, discusses the affordability of cancer treatments at the 2017 International Workshop in Non-Hodgkin Lymphoma (iwNHL) in Vancouver, BC, Canada. There are various novel agents being developed, however, current costs make some treatments unaffordable. Therefore, there needs to be negotiations with pharmaceutical companies to bring down the costs, and improve the availability of treatments.

More from Steven Rosen

2:03
The challenging field of hem-onc therapeutics
Steven Rosen • 21 Sep 2018
1:09
Non-hodgkin lymphoma advances in 2018
Steven Rosen • 21 Sep 2018
1:33
CAR T-cell therapy: on the way to success
Steven Rosen • 21 Sep 2018
1:22
Update on CAR T-cell therapy at the City of Hope
Steven Rosen • 27 Sep 2018

Related Videos

3:32
Improving CAR-T therapy for ALL & lymphoma: allogeneic products & reducing CRS/ICANS
Sridhar Chaganti • 16 Apr 2024
2:11
The role of CAR-T therapy for lymphoma in 2024: expert session highlights
Sridhar Chaganti • 16 Apr 2024
3:03
AlloSCT outcomes after immunotherapy vs chemotherapy in patients with R/R NHL: a retrospective study
Jacopo Mariotti • 15 Apr 2024
1:37
Exciting CAR-T clinical trials in LBCL and FL
Gloria Iacoboni • 15 Apr 2024
The content of VJHemOnc is intended for healthcare professionals